缓控释制剂

  • 网络sustained and controlled release preparations;sustained or controlled release dosage forms
缓控释制剂缓控释制剂
  1. 缓控释制剂价格偏高。

    The prices of sustained and controlled release preparations were high .

  2. 口服缓控释制剂研究概况

    A review of research on oral sustained and controlled release preparations

  3. 因此,有必要开发新型5-FU口服缓释制剂,延长药物的半衰期,提高生物利用度。口服缓控释制剂研究概况

    So it is necessary to exploit new slow-release system for 5-FU . A review of research on oral sustained and controlled release preparations

  4. Ivermectin缓控释制剂的研究进展

    Development of Ivermectin Sustained-release and Controlled-released Formulations

  5. 固体分散技术在缓控释制剂中的应用

    Application of Solid Dispersion Technology in Sustained and Controlled Release Preparations

  6. 本文综述了这几类口服缓控释制剂的最新研究动态。

    This review provides the latest advances on these research areas .

  7. 口服缓控释制剂的研究进展及临床应用

    Research Progress and Clinical Application of Orally Sustained Release Preparations

  8. 硝苯地平缓控释制剂制备技术研究进展

    Research progress of techniques for preparation of nifedipine sustained and controlled release preparation

  9. 难溶性药物洛伐他汀缓控释制剂的研究缓释药物纤维的发展

    Studies on Sustained-Release and Controlled-Release Tablets of Insoluble Lovastatin Development of slow-release iatric fiber

  10. 胃滞留漂浮型缓控释制剂的研究概况

    Advance on Controlled-and Sustained-release Dosage Forms Remaining Floating in Stomach with Prolonged Gastric Resident Time

  11. 偏离度&缓控释制剂处方优化的指标

    Study on deviation as an index for formulation optimization of sustained or controlled release dosage forms

  12. 动力学方程的研究可以指导缓控释制剂载体的制备,进一步提高药物的缓控释性能。

    Drug delivery matrix fabrication would be guided and release property be improved by studying on release kinetics .

  13. 中生菌素缓释粒剂研制及控释机理研究缩核模型在缓控释制剂药物释放中的应用

    Preparation and Mechanism of Controlled-release Granular Formulation of Zhongshengmycin ; The Application of Shrinking-core Model in Sustained and Controlled Release Pharmaceuticals

  14. 关于缓控释制剂的处方优化指标中药缓控释微丸制剂的研究进展

    Study on index for formulation optimization of sustained or controlled released dosage forms Advances of sustained / controlled release pellets in traditional Chinese medicine

  15. 结果羟丙基纤维素在片剂、胶囊剂、黏膜黏附制剂、缓控释制剂等多种制剂以及薄膜包衣方面均有良好应用。

    RESULTS Hydroxypropyl cellulose is extensively used in tablets , capsules , mucous membrane adhesion preparation , sustained or controlled release preparation , and film coating , etc.

  16. 口服给药是全身给药的最简单便捷的给药途径,人们尝试了很多方法来制备口服缓控释制剂,以达到提高药物生物利用度,减少给药次数的目的。

    Oral ingestion is the predominant and most preferable route for drug delivery . People have tried a lot to develop oral sustained-release preparation in order to improve the bioavailability and decrease administration times .

  17. 随着科技的进步和新型辅料的发展,缓控释制剂、透皮吸收制剂、靶向给药制剂等新剂型、新技术日趋成熟。

    With the advancement of technology and the development of new excipients , controlled release formulations , transdermal absorption agents , targeted drug delivery formulations and other new dosage forms , new technologies are mature .

  18. 从处方组成、制备工艺、体外释药影响因素等方面,综述半固体骨架制剂技术在缓控释制剂中的应用。

    In this article , the application of SSM in preparing sustained release pharmaceutical formulations was summarized in the respects of their compositions , preparations , influencing factors on their in vitro release and so on .

  19. 它是生物等效性评价的重要指标,也是缓控释制剂处方优化、稳定性考察、生产过程的质量控制等方面的重要参数。

    It is not only the important indexes for evaluation of bioequivalence , also the important parameter of formulation optimization , study of the stability and quality control within producing of sustained or controlled release dosage forms .

  20. 目的:结合剂型、临床应用等方面,评价我国中药缓控释制剂的特点,并对研究过程中存在的问题和发展前景作了初步分析。

    Objective : To evaluate the characteristics of slow and controlled release agents of traditional Chinese medicine ( TCM ) and make a preliminary analysis on problems and prospect during the study of TCM , in aspects of agents and clinical application .

  21. 口服缓、控释制剂使用中存在的问题

    Problem of oral Sustained-release and controlled-release preparation Existing in Being Used

  22. 缓/控释制剂的国外研究动向

    The trend in Foreign Studies on sustained / controlled release preparations

  23. 果胶及果胶钙在缓、控释制剂中的应用

    Pectinate and Calcium Pectinate for Delayed and Controlled Release Drug Delivery

  24. 我院常用口服缓、控释制剂使用情况调查分析

    Investigation On The Usage Of The Sustained / Controlled Release Tablets Of Our Hospital

  25. 口服缓/控释制剂的体外释放度试验概述

    Overview of in vitro release testing of sustained or controlled - release oral dosage form

  26. 结论钙拮抗药应用趋势是二氢吡啶类药物前景看好,缓、控释制剂应用将更普遍。

    Conclusions Dihydropyridine calcium antagonist is promising , and the sustained release preparation or controlled release preparation would be more and more frequently used .

  27. 目的对我院常用口服缓释制剂、控释制剂的使用情况进行调查,了解其使用情况,为临床上合理使用缓、控释制剂提供参考。

    Objective To provide the clinic reference to the better usage of the sustained / controlled release tablets via investigation of the practice in our hospital .

  28. 尤其是缓、控释制剂以其生物利用度高、患者顺应性好、制备工艺简单等优点而备受医药届人士青睐。

    Especially the sustained and controlled release formulations for its high degree of bioavailability , good patient compliance , simple process , are very popular with people .

  29. 口服缓/控释药物制剂技术研究进展

    Development of Technology of Oral Sustained / Controlled Release Preparations

  30. 结论:研究口服缓/控释药物制剂技术,对提高药物疗效、开展临床药学研究、推动医药科研和制药工业的发展具有重要的意义。

    Conclusion : It is meaningful to study the technology of oral sustained / controlled release preparations for raising medicine curative effect , developing research on clinical medicine , promoting the development of medicine research and pharmacy industry .